TCR2
TCR2 develops and commercializes T cell receptor therapies for the treatment of hematological malignancies and solid tumors.
Business Model:
Revenue: $0
Employees: 51-200
Industries / Tags:
Detailed TCR2 Information
Geographic Data
Address: 100 Binney Street
City: Cambridge
State: MA
Zip: 02142
Country: US
Financial Info
Stage:
series b
Raised Last:
$125M
Raised Total:$173M
Social
Metrics
4,750,902Website Global Rank
1,823Website Monthly Traffic
Twitter Followers
Description
TCR2 develops and commercializes T cell receptor therapies for the treatment of hematological malignancies and solid tumors.
Contact Phone:
+16179495200
Contact Email:
TCR2 went public on 2/13/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
2/13/2019
IPO Valuation:
$348M
Ticker Symbol:
TCRR
IPO Price:
$15/share
Amount Raised:
$75M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
